XUE [Xueda Education] CORRESP: VIA EDGAR August 7, 2012 Larry Spirgel, Assistant

[VIA EDGAR August 7, 2012 Larry Spirgel, Assistant Director Kate Beukenkamp, Attorney-Advisor Terry French, Account Branch Chief Claire DeLabar, Staff Accountant Division of Corporation Finance Re: Xueda Education Group Form 20-F for Fiscal Year Ended December 31, 2011 Filed April 27, 2012 File No. 001-34914 Dear Mr. Spirgel , Ms. Murphy, Ms. Beukenkamp, Mr. French and Ms. DeLabar: If you]

By | 2016-03-18T10:39:20+00:00 August 7th, 2012|Categories: Chinese Stocks, Webplus ver, XUE|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2012 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2012 Financial Results Shenzhen, China – August 6, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2012. Highlights for Second Quarter 2012 • Net revenues were $267.8 million, an increase of 23.3%]

BSPM [Biostar Pharmaceuticals,] 8-K: BIOSTAR PHARMACEUTICALS, INC. RECEIVES APPROVAL FROM XIANYANG SFDA

[BIOSTAR PHARMACEUTICALS, INC. RECEIVES APPROVAL FROM XIANYANG SFDA TO RESTART SALES OF ITS GEL CAPSULE DRUGS XIANYANG, China, August 3, 2012 - Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that on July 30, 2012, after]

By | 2016-03-03T11:56:01+00:00 August 6th, 2012|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2012 Financial Results STYLE=”font-family:Times

[Mindray Announces Second Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August6, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2012. Highlights for Second Quarter 2012 Net revenues were $267.8 million,]

OIIM [O2MICRO INTERNATIONAL] 6-K: O2Micro Reports Second Quarter Results 2 ® GEORGE

[O2Micro Reports Second Quarter Results 2 ® GEORGE TOWN, Grand Cayman, Aug. 1, 2012 (GLOBE NEWSWIRE) -- O Financial Highlights for the Second Quarter ending June 30, 2012 2 O GAAP net loss was $10.9 million in Q2 2012. This compares to GAAP net income of $44,000 in the first quarter of 2012 and GAAP net income of $3.0 million]

By | 2016-03-01T22:49:34+00:00 August 6th, 2012|Categories: Chinese Stocks, OIIM, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar